Human Research"font-size: 18pt;">Antioxidant alpha lipoic acid may help diabetics control blood sugar.
Alpha lipoic acid is a natural substance known for its antioxidant effects and is frequently used as a supplement. Alpha lipoic acid has been suggested to help control blood sugar by:
- Activating AMPK. This enzyme promotes the usage of glucose for energy, which can help reduce elevated blood sugar levels.
Alpha lipoic acid (ALA) is a fatty acid compound naturally present in the human body and many foods. ALA’s major role is to support the function of enzymes in the mitochondria—the structures which generate cellular energy. In addition to this, ALA also functions as the body’s “universal” antioxidant because of its unique ability to dissolve in both water and fat.
ALA is a popular supplement for health disorders linked to energy metabolism and oxidative stress, such as diabetes, obesity, dementia, chronic fatigue, and liver disorders. As part of its anti-diabetic effects, many people also use ALA to lower elevated blood sugar levels. Good sources of ALA include spinach, broccoli, potatoes, yeast, tomatoes, brussels sprouts, and kidney meat.
However, as one group of researchers concluded, the “lack of clear-cut benefits in some of the clinical trials to date does not disprove the benefits of ALA.” 3 As such, ALA is certainly worth trying for blood sugar control.
Read more: Guide to Blood Sugar Supplements
Human studies of alpha lipoic acid’s effects on blood sugar are inconclusive, with some studies demonstrating reduction of blood sugar levels and improvement of insulin sensitivity, and others showing minor benefits or no effect at all.
This randomized, double-blind, placebo-controlled study evaluated the effects of ALA on diabetes. A total of 57 type 2 diabetics were given placebo or ALA (300 mg) daily for 8 weeks. ALA supplementation decreased fasting blood glucose (FBG) and postmeal blood glucose levels, as well as measures of insulin resistance.
- The researchers concluded that “This study supports the use of ALA as an antioxidant in the care of diabetic patients.” 5
This randomized, double-blind, placebo-controlled study examined the effects of ALA and vitamin E on insulin sensitivity in diabetes. Being sensitive to insulin helps maintain healthy blood sugar levels. A total of 102 type 2 diabetics were given ALA (600 mg), vitamin E, both, or placebo. The study participants did not experience a significant improvement of blood glucose or insulin sensitivity, although the researchers did note a slight improvement in the ALA group.
- The researchers concluded that “…LA and vitamin E supplementation alone or in combination did not affect the lipid profile or insulin sensitivity of DM2 patients.” 6
This randomized study looked at the effects of ALA on insulin in type 2 diabetes. Twelve diabetics were given ALA (600 mg twice daily) for 4 weeks. The supplementation improved markers of insulin sensitivity, which suggests that it can help control blood sugar in diabetics.
- The researchers concluded that “short-term oral alpha-lipoic acid treatment increases peripheral insulin sensitivity in patients with type 2 diabetes mellitus.” 7
This placebo-controlled study examined whether ALA can improve insulin sensitivity. Nineteen type 2 diabetics were given a single dose of ALA (1000 mg) or placebo. ALA increased insulin-stimulated blood glucose disposal, meaning that ALA made insulin more effective at controlling blood sugar.
- The researchers concluded that “…ALA and its potential use as an antihyperglycemic agent require further investigation.” 8
This randomized, double-blind, placebo-controlled study evaluated the effects of ALA on glucose levels in diabetes. A total of 38 type 2 diabetics were given placebo or different doses of ALA (300, 600, 900, or 1200 mg) daily for 6 months. Although the results showed small reductions in fasting blood sugar and HbA1c levels, these effects were not significant enough to conclusively support ALA’s effectiveness.
- The researchers concluded that ” Results from this study reflected the benefits of ALA in glucose status with slight efficiency…” 9
Dosage for Blood Sugarl>
Supplements in Review Recommendationl>
Alpha lipoic acid may help lower blood sugar. It’s too early to recommend ALA for lowering blood sugar in diabetics because of mixed research findings. However, there are enough studies showing improvements in blood sugar to justify trying ALA to see if it works for you.
Successful studies use dosages of 300-1200 mg. We recommend starting out with 300 mg daily dosages of ALA, after which you can assess the effects and consider moving up to higher dosages.
- Maryam Akbari et al. The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Nutrition & Metabolism 2018 15:39 ↩
- Lee WJ et al. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem Biophys Res Commun. 2005 Jul 8;332(3):885-91. ↩
- Saeid Golbidi et al. Diabetes and Alpha Lipoic Acid. Front Pharmacol. 2011; 2: 69. ↩
- Gerritje S. Mijnhout et al. Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials. Int J Endocrinol. 2012; 2012: 456279. ↩
- Ansar H et al. Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med J. 2011 Jun;32(6):584-8. ↩
- de Oliveira AM et al. The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Diabetes Res Clin Pract. 2011 May;92(2):253-60. ↩
- Kamenova P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones (Athens). 2006 Oct-Dec;5(4):251-8. ↩
- Jacob S et al. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung. 1995 Aug;45(8):872-4. ↩
- Porasuphatana S et al. Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study. Asia Pac J Clin Nutr. 2012;21(1):12-21. ↩